HC Wainwright Lowers Neurogene (NASDAQ:NGNE) Price Target to $50.00

Neurogene (NASDAQ:NGNE – Get Free Report) had its price target cut by analysts at HC Wainwright from $55.00 to $50.00 in a research report issued to clients and investors on Tuesday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price target would indicate a potential upside of 209.79% from the […]

Leave a Reply

Your email address will not be published.

Previous post HC Wainwright Increases Larimar Therapeutics (NASDAQ:LRMR) Price Target to $16.00
Next post Comparing Proficient Auto Logistics (NASDAQ:PAL) & Tuniu (NASDAQ:TOUR)